Novartis Investigative Site

Idaho Falls, Idaho 83404

0 studies enrolling now · 5 studies all time

What they study most

COVID-19 Pneumonia, Impaired Respiratory Function, Cytokine Storm (Covid-19), Moderate Clostridium Difficile Infection, Non-radiographic Spondyloarthritis, Relapsing Forms of Multiple Sclerosis

Studies at this site

• Study of Efficacy and Safety of MAS825 in Patients With COVID-19 — Completed
• Study of Efficacy and Safety of Secukinumab in Patients With Non-radiographic Axial Spondyloarthritis — Completed
• Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm — Completed
• Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections — Completed
• A 6-month, Randomized, Open-label, Patient OutComes, Safety and Tolerability Study of Fingolimod (FTY720) 0.5 mg/Day vs. Comparator in Patients With Relapsing Forms of Multiple Sclerosis — Completed